NCT05389215: Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
- State
- Under way
- Phase
- Phase 2
- People
- 102 planned
- Started
- 29 Jul 2022
- Primary completion
- 13 Oct 2026
- Arms
- DWN12088 Xmg Tablet (BID)
- Results
- None posted
- 25 May 2022: Trial registered
- 29 Jul 2022: Trial started